MedTrace Logo

Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease

NCT07317297 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-01-16

No results posted yet for this study

Summary

Investigation of the effectiveness of extracorporeal shock wave therapy in the treatment of Peyronie's disease.

Conditions

  • Peyronie Disease

Interventions

OTHER

Extracorporeal Shockwave Therapy

Extracorporeal Shockwave Therapy will follow a standard protocol. The treatment is planned as a total of 8 sessions (3000 pulses per session, 2.5 bar pressure, 15 Hz frequency) twice a week using a radial shockwave device. Focusing will be done on the penile shaft via gel according to the plaque localization, and shock waves will be applied to the plaque area.

OTHER

control

patients receiving normal routine pharmacological treatment without any special intervention

Sponsors & Collaborators

  • Uskudar University

    lead OTHER

Principal Investigators

  • Aziz Azizov · Uskudar University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-10
Primary Completion
2026-02-15
Completion
2026-03-30

Countries

  • Azerbaijan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07317297 on ClinicalTrials.gov